210 related articles for article (PubMed ID: 29699590)
1. Attenuation of TGFBR2 expression and tumour progression in prostate cancer involve diverse hypoxia-regulated pathways.
Zhou H; Wu G; Ma X; Xiao J; Yu G; Yang C; Xu N; Zhang B; Zhou J; Ye Z; Wang Z
J Exp Clin Cancer Res; 2018 Apr; 37(1):89. PubMed ID: 29699590
[TBL] [Abstract][Full Text] [Related]
2. Involvement of aberrantly activated HOTAIR/EZH2/miR-193a feedback loop in progression of prostate cancer.
Ling Z; Wang X; Tao T; Zhang L; Guan H; You Z; Lu K; Zhang G; Chen S; Wu J; Qian J; Liu H; Xu B; Chen M
J Exp Clin Cancer Res; 2017 Nov; 36(1):159. PubMed ID: 29141691
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-132/212 Upregulation Inhibits TGF-β-Mediated Epithelial-Mesenchymal Transition of Prostate Cancer Cells by Targeting SOX4.
Fu W; Tao T; Qi M; Wang L; Hu J; Li X; Xing N; Du R; Han B
Prostate; 2016 Dec; 76(16):1560-1570. PubMed ID: 27527117
[TBL] [Abstract][Full Text] [Related]
4. Loss of TGF-β signaling in osteoblasts increases basic-FGF and promotes prostate cancer bone metastasis.
Meng X; Vander Ark A; Daft P; Woodford E; Wang J; Madaj Z; Li X
Cancer Lett; 2018 Apr; 418():109-118. PubMed ID: 29337106
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1alpha/HIF-1beta.
Cao P; Deng Z; Wan M; Huang W; Cramer SD; Xu J; Lei M; Sui G
Mol Cancer; 2010 May; 9():108. PubMed ID: 20478051
[TBL] [Abstract][Full Text] [Related]
6. Adiponectin as a potential tumor suppressor inhibiting epithelial-to-mesenchymal transition but frequently silenced in prostate cancer by promoter methylation.
Tan W; Wang L; Ma Q; Qi M; Lu N; Zhang L; Han B
Prostate; 2015 Aug; 75(11):1197-205. PubMed ID: 25877612
[TBL] [Abstract][Full Text] [Related]
7. miR-20b-5p, TGFBR2, and E2F1 Form a Regulatory Loop to Participate in Epithelial to Mesenchymal Transition in Prostate Cancer.
Qi JC; Yang Z; Zhang YP; Lu BS; Yin YW; Liu KL; Xue WY; Qu CB; Li W
Front Oncol; 2019; 9():1535. PubMed ID: 32010624
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway.
Ren D; Yang Q; Dai Y; Guo W; Du H; Song L; Peng X
Mol Cancer; 2017 Jul; 16(1):117. PubMed ID: 28693582
[TBL] [Abstract][Full Text] [Related]
9. Sensitization of Gastric Cancer Cells to 5-FU by MicroRNA-204 Through Targeting the TGFBR2-Mediated Epithelial to Mesenchymal Transition.
Li LQ; Pan D; Chen Q; Zhang SW; Xie DY; Zheng XL; Chen H
Cell Physiol Biochem; 2018; 47(4):1533-1545. PubMed ID: 29940566
[TBL] [Abstract][Full Text] [Related]
10. MiR-17-5p regulates cell proliferation and migration by targeting transforming growth factor-β receptor 2 in gastric cancer.
Qu Y; Zhang H; Duan J; Liu R; Deng T; Bai M; Huang D; Li H; Ning T; Zhang L; Wang X; Ge S; Zhou L; Zhong B; Ying G; Ba Y
Oncotarget; 2016 May; 7(22):33286-96. PubMed ID: 27120811
[TBL] [Abstract][Full Text] [Related]
11. Autoregulatory feedback loop of EZH2/miR-200c/E2F3 as a driving force for prostate cancer development.
Tao T; Liu D; Liu C; Xu B; Chen S; Yin Y; Ang L; Huang Y; Zhang X; Chen M
Biochim Biophys Acta; 2014 Sep; 1839(9):858-65. PubMed ID: 25017995
[TBL] [Abstract][Full Text] [Related]
12. Involvement of EZH2 in aerobic glycolysis of prostate cancer through miR-181b/HK2 axis.
Tao T; Chen M; Jiang R; Guan H; Huang Y; Su H; Hu Q; Han X; Xiao J
Oncol Rep; 2017 Mar; 37(3):1430-1436. PubMed ID: 28184935
[TBL] [Abstract][Full Text] [Related]
13. A reciprocal role of prostate cancer on stromal DNA damage.
Banerjee J; Mishra R; Li X; Jackson RS; Sharma A; Bhowmick NA
Oncogene; 2014 Oct; 33(41):4924-31. PubMed ID: 24141771
[TBL] [Abstract][Full Text] [Related]
14. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis.
Saini S; Majid S; Yamamura S; Tabatabai L; Suh SO; Shahryari V; Chen Y; Deng G; Tanaka Y; Dahiya R
Clin Cancer Res; 2011 Aug; 17(16):5287-98. PubMed ID: 21159887
[TBL] [Abstract][Full Text] [Related]
15. Methylation silencing of transforming growth factor-beta receptor type II in rat prostate cancers.
Yamashita S; Takahashi S; McDonell N; Watanabe N; Niwa T; Hosoya K; Tsujino Y; Shirai T; Ushijima T
Cancer Res; 2008 Apr; 68(7):2112-21. PubMed ID: 18381416
[TBL] [Abstract][Full Text] [Related]
16. Androgen receptor and microRNA-21 axis downregulates transforming growth factor beta receptor II (TGFBR2) expression in prostate cancer.
Mishra S; Deng JJ; Gowda PS; Rao MK; Lin CL; Chen CL; Huang T; Sun LZ
Oncogene; 2014 Jul; 33(31):4097-106. PubMed ID: 24037531
[TBL] [Abstract][Full Text] [Related]
17. Identification of miR-135b as a novel regulator of TGFβ pathway in gastric cancer.
Bai M; Wang P; Yang J; Zuo M; Ba Y
J Physiol Biochem; 2020 Nov; 76(4):549-560. PubMed ID: 32737704
[TBL] [Abstract][Full Text] [Related]
18. MiR-26a and miR-138 block the G1/S transition by targeting the cell cycle regulating network in prostate cancer cells.
Erdmann K; Kaulke K; Rieger C; Salomo K; Wirth MP; Fuessel S
J Cancer Res Clin Oncol; 2016 Nov; 142(11):2249-61. PubMed ID: 27562865
[TBL] [Abstract][Full Text] [Related]
19. NEDD9 crucially regulates TGF-β-triggered epithelial-mesenchymal transition and cell invasion in prostate cancer cells: involvement in cancer progressiveness.
Morimoto K; Tanaka T; Nitta Y; Ohnishi K; Kawashima H; Nakatani T
Prostate; 2014 Jun; 74(8):901-10. PubMed ID: 24728978
[TBL] [Abstract][Full Text] [Related]
20. Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent growth and invasion in metastatic prostate cancer cells.
Jones DZ; Schmidt ML; Suman S; Hobbing KR; Barve SS; Gobejishvili L; Brock G; Klinge CM; Rai SN; Park J; Clark GJ; Agarwal R; Kidd LR
BMC Cancer; 2018 Apr; 18(1):421. PubMed ID: 29653561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]